Circulating CD14+HLA-DR−/low Myeloid-Derived Suppressor Cells as Potential Biomarkers for the Identification of Psoriasis TCM Blood-Heat Syndrome and Blood-Stasis Syndrome

<div>Correlation analyses of psoriasis severity as assessed by the psoriasis area and severity index (PASI) and the percentage of circulating Mo-MDSCs among CD14+ monocytes. (a) PASI and percentage of circulating Mo-MDSCs among CD14+ monocytes in the BH group (n = 20); (b) PASI and percentage of circulating Mo-MDSCs among CD14+ monocytes in the BS group (n = 22); (c) PASI and percentage of circulating Mo-MDSCs among CD14+ monocytes in all psoriasis patients.</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: Circulating CD14+HLA-DR−/low Myeloid-Derived Suppressor Cells as Potential Biomarkers for the Identification of Psoriasis TCM Blood-Heat Syndrome and Blood-Stasis Syndrome

Figure 2 | Circulating CD14+HLA-DR−/low Myeloid-Derived Suppressor Cells as Potential Biomarkers for the Identification of Psoriasis TCM Blood-Heat Syndrome and Blood-Stasis Syndrome 